Premium Nahrungsergänzungsmittel | artgerecht

Hepatic Encephalopathy – Causes and Treatment

Hepatic encephalopathy is a brain dysfunction caused by severe liver disease. It leads to confusion, impaired consciousness, and neurological deficits due to the buildup of toxic substances in the blood.

Regular tips about health Regular tips about health

Things worth knowing about "Hepatic Encephalopathy"

Hepatic encephalopathy is a brain dysfunction caused by severe liver disease. It leads to confusion, impaired consciousness, and neurological deficits due to the buildup of toxic substances in the blood.

What is Hepatic Encephalopathy?

Hepatic encephalopathy (HE) is a serious complication of liver disease in which brain function becomes impaired. It occurs when the liver can no longer adequately remove toxic metabolic byproducts – most notably ammonia – from the bloodstream. These substances cross the blood-brain barrier and disrupt normal neurological function. Hepatic encephalopathy most commonly affects patients with liver cirrhosis, acute liver failure, or portosystemic shunts.

Causes

The primary cause of hepatic encephalopathy is impaired liver detoxification function. Key underlying conditions and triggering factors include:

Liver cirrhosis: The most common predisposing condition, in which healthy liver tissue is replaced by scar tissue
Acute liver failure: Sudden and severe loss of liver function, e.g., due to drug toxicity or viral hepatitis
Portosystemic shunts: Collateral blood vessels that bypass the liver, allowing toxins to enter the systemic circulation unfiltered
Precipitating factors: Infections, gastrointestinal bleeding, constipation, certain medications (e.g., sedatives), excessive protein intake, or electrolyte imbalances

Symptoms

The symptoms of hepatic encephalopathy range from subtle cognitive changes to deep coma. The condition is graded using the West Haven Criteria:

Grade I: Mild confusion, mood changes, sleep disturbances, reduced attention span
Grade II: Disorientation, lethargy, abnormal behavior, asterixis (flapping tremor of the hands)
Grade III: Marked confusion, somnolence, barely responsive, incoherent speech
Grade IV: Deep coma, no response to painful stimuli

A characteristic fetor hepaticus – a sweet, musty odor on the breath – may also be present, caused by volatile metabolic byproducts of impaired liver metabolism.

Diagnosis

Diagnosis is based on a combination of clinical assessment, laboratory findings, and imaging:

Clinical evaluation: Assessment of consciousness and neurological symptoms using the West Haven Criteria
Laboratory tests: Elevated blood ammonia levels, liver function parameters (bilirubin, ALT, AST, INR/prothrombin time), full blood count, electrolytes
Psychometric testing: To detect minimal or covert hepatic encephalopathy (e.g., Number Connection Test)
EEG: Detection of characteristic slow-wave activity (theta and delta waves)
Imaging: MRI or CT of the brain to exclude other causes such as stroke or intracranial bleeding

Treatment

Treatment of hepatic encephalopathy focuses on eliminating precipitating factors, lowering ammonia levels, and supporting brain function.

General Measures

Identification and treatment of triggering factors (e.g., treating infections, managing gastrointestinal bleeding)
Medication review and adjustment (e.g., discontinuing sedatives or diuretics)
Adequate caloric intake with appropriate protein supply – a blanket protein restriction is no longer recommended

Pharmacological Therapy

Lactulose: A non-absorbable disaccharide that accelerates intestinal transit and reduces gut ammonia production – considered first-line treatment
Rifaximin: A minimally absorbed antibiotic that suppresses ammonia-producing gut bacteria; primarily used for secondary prevention of episodes
Zinc supplementation: Zinc is involved in the urea cycle and ammonia detoxification; deficiency is common in liver cirrhosis
L-ornithine L-aspartate (LOLA): Supports ammonia detoxification via the urea cycle and glutamine synthesis

Causal Treatment

In advanced liver disease, liver transplantation may be the only curative option. It addresses the underlying disease and typically leads to significant improvement or complete resolution of hepatic encephalopathy.

Prognosis and Course

The prognosis depends heavily on the severity of the underlying liver disease and the grade of encephalopathy. Episodic hepatic encephalopathy triggered by a clearly identifiable cause is often reversible and manageable with appropriate treatment. Persistent or recurrent hepatic encephalopathy, however, indicates severe hepatic dysfunction and is associated with a significantly poorer prognosis. Without treatment, acute liver failure with severe hepatic encephalopathy can be life-threatening.

References

European Association for the Study of the Liver (EASL): Clinical Practice Guidelines on the Management of Hepatic Encephalopathy. Journal of Hepatology, 2022.
Vilstrup H. et al.: Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology, 2014.
Ferenci P. et al.: Hepatic Encephalopathy – Definition, Nomenclature, Diagnosis, and Quantification. Hepatology, 2002.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.